chronic lymphocytic leukaemia

News

Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood and bone marrow - the spongy tissue inside bones where blood cells are made.

TG Therapeutics cancer trial setback sends shares tumbling

TG Therapeutics (TG) has suffered a setback in its blood cancer drug trial, as the data available was deemed not ready for analysis.

News

Roche/AbbVie drug could further improve prognosis in CLL

Roche/AbbVie’s cancer drug venetoclax, which is set to become standard of care in chronic lympocytic leukaemia, could further improve prognosis earlier in the disease according to a UK expe

News

Roche/AbbVie combination could raise standards in CLL

A leukaemia combination therapy could help revive the fortunes of Roche and AbbVie, following late-stage trial results showing it significantly reduces risk of progression in CLL compared w

News

Leukaemia patients to get access to AbbVie's Venclyxto via C...

Cancer Drugs Fund will reimburse medicine on interim basis

News

Novartis' Basel HQ: the company is looking for more blockbusters to lift revenues

Spectacular early results for Novartis’ CAR-T combined with ...

A combination of Novartis’ 'next generation' CAR-T drug CTL119 with Janssen and AbbVie's Imbruvica has cleared all signs of chronic lymphocytic leukaemia from eight out of nine patients in

News